Skip to content

Author

L. Hoekman

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Nov 2026

ABCB1, ABCG2, and CES1 are Key Determinants of the Pharmacokinetics of KRASG12C Inhibitor Divarasib

Divarasib is a selective KRASG12C inhibitor currently in phase 3 trials for treatment of NSCLC. Drug transporters and metabolic enzymes can markedly influence oral drug disposition. We therefore examined whether the efflux transporters ABCB1 and ABCG2, the influx transporter OATP1, and the enzymes CYP3A and CES1 affe...

J. Rijmers, Viët Bui, Daniëlle C. Band et al. · 0 citations
Open access Jul 2026

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

Immunity protection from macrophages is revealed as an adverse consequence of hormonal therapy in prostate cancer patients using a genome-wide co-culture CRISPR screen and positions tumor-intrinsic AR signaling as a bona fide immunomodulatory pathway.

Anniek Zaalberg, Audrey Lacoste, Emma Minnee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.